Form 4: Mind Medicine (MindMed) Inc. Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Dan Karlin, Chief Medical Officer of Mind Medicine (MindMed) Inc., sold shares to cover withholding tax obligations related to vested restricted stock units.
Summary
- On September 25, 2024, Dan Karlin, the Chief Medical Officer of Mind Medicine (MindMed) Inc., sold 6,871 common shares of the company.
- The sale was executed to satisfy withholding tax obligations related to the settlement of vested restricted stock units.
- The shares were sold at a weighted average price of $5.98, with individual transactions ranging from $5.95 to $6.07.
- Following the transaction, Karlin still beneficially owns 344,656 common shares of Mind Medicine (MindMed) Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) and doesn't indicate any significant positive or negative sentiment.
Industry Context
Sales of shares by company executives are a normal part of corporate governance. Often these sales are pre-planned to avoid any accusations of insider trading.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant long-term effect.
Key Dates
| Date | Description |
|---|---|
| June 14, 2022 | Date of adoption of Rule 10b5-1 plan. |
| September 25, 2024 | Date of the share sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.